Kanna Health anuncia las aprobaciones de la FDA y la MHRA para iniciar su ensayo clínico de fase 1 de KH-001

Kanna Health Ltd Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America England

View original content:https://www.prnewswire.com/news-releases/kanna-health-anuncia-las-aprobaciones-de-la-fda-y-la-mhra-para-iniciar-su-ensayo-clinico-de-fase-1-de-kh-001-301990921.html